Skip to content
healthcare.dev

Glycopyrrolate

NDC 16571-744, Glycopyrrolate, tablet, from Rising Pharma Holdings, Inc..

Product NDC
16571-744
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA012827
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16571-744 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GLYCOPYRROLATE2 mg/1

Pharmacologic classes

Anticholinergic [EPC]; Cholinergic Antagonists [MoA]; Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]

Package NDCNDC-11Package
16571-744-031657107440330 TABLET in 1 CONTAINER (16571-744-03)
16571-744-091657107440990 TABLET in 1 CONTAINER (16571-744-09)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/58c4cb1f-59b8-4be9-a222-2264ca077d93
  • NADAC price for package 16571074409

    GET /v1/drugs/nadac/16571074409

Use it

Look up 16571-744 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16571-744 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16571-744. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.